美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Apimeds Pharmaceutical U.S, Inc.

4.84

+0.450010.25%

盘后：5.070.2328+4.81%19:59 EDT

成交量：55.95万

成交额：264.80万

市值：730.41万

市盈率：-0.13

高：5.43

开：4.30

低：4.18

收：4.39

52周最高：59.70

52周最低：3.39

股本：150.91万

流通股本：30.47万

量比：1.63

换手率：183.61%

股息：- -

股息率：- -

每股收益(TTM):-38.5450

每股收益(LYR):-0.1759

净资产收益率：-144.99%

总资产收益率：-69.29%

市净率：0.90

市盈率(LYR):-27.52

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

SEC文件揭示：Freet已将全部Apitox相关权利转让予Apimeds Pharmaceuticals

Apimeds Pharmaceuticals US获Apitox韩国诊所独家权利、美国25%特许权使用费及海外25%收入分成——SEC文件披露

Apimeds制药美国公司依据和解协议，将在七个工作日内设立全新全资子公司

Apimeds Pharmaceuticals US与Inscobee达成和解；合并进程继续，1亿美元PIPE融资即将完成，LŌKahi Therapeutics将推进Apitox项目

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/APUS"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"APUS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APUS\",,,,,undefined,":{"symbol":"APUS","market":"US","secType":"STK","nameCN":"Apimeds Pharmaceutical  U.S, Inc.","latestPrice":4.84,"timestamp":1787342400000,"preClose":4.39,"halted":0,"volume":559526,"hourTrading":{"tag":"盘后","latestPrice":5.0728,"preClose":4.84,"latestTime":"19:59 EDT","volume":4328,"amount":22038.1559,"timestamp":1787356786654,"change":0.2328,"changeRate":0.048099,"amplitude":0.113636},"delay":0,"changeRate":0.1025056947608201,"floatShares":304730,"shares":1509119,"eps":-38.545,"marketStatus":"休市中","change":0.45,"latestTime":"08-21 16:00:00 EDT","open":4.3,"high":5.43,"low":4.175,"amount":2648015.824993,"amplitude":0.285877,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-38.545,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1746763200000,"exchange":"AMEX","adjPreClose":4.39,"preHourTrading":{"tag":"盘前","latestPrice":4.04,"preClose":4.39,"latestTime":"09:27 EDT","volume":23275,"amount":107355.61164999999,"timestamp":1787318834071,"change":-0.35,"changeRate":-0.079727,"amplitude":0.535308},"postHourTrading":{"tag":"盘后","latestPrice":5.0728,"preClose":4.84,"latestTime":"19:59 EDT","volume":4328,"amount":22038.1559,"timestamp":1787356786654,"change":0.2328,"changeRate":0.048099,"amplitude":0.113636},"volumeRatio":1.6295589706308973},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APUS\",,,,,undefined,":{"symbol":"APUS","floatShares":304730,"roa":"-69.29%","roe":"-144.99%","lyrEps":-0.175862,"volumeRatio":1.6295589706308973,"shares":1509119,"dividePrice":0,"high":5.43,"amplitude":0.285877,"preClose":4.39,"low":4.175,"week52Low":3.39,"pbRate":"0.90","week52High":59.7,"institutionHeld":0,"latestPrice":4.84,"eps":-38.545,"divideRate":0,"volume":559526,"delay":0,"ttmEps":-38.545,"open":4.3,"prevYearClose":16.4,"prevWeekClose":4.55,"prevMonthClose":5.15,"prevQuarterClose":9,"fiveDayClose":4.55,"twentyDayClose":5.65,"sixtyDayClose":14.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APUS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-24","symbol":"APUS","defaultRemindTime":1784899800000,"type":"split","dateTimestamp":1784865600000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APUS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APUS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APUS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APUS","date":"2025-12-01","current":-0.125568,"percent":0.642384,"low":-37.866629,"twenty":-14.293061,"median":-12.284712,"eighty":-6.374893,"high":-4.754876,"avg":-11.953693,"sd":7.073766,"marketCap":36470350},"quantilePoints":[{"date":"2025-02-21","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-02-28","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-03-05","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-05-09","current":-18.309826,"twenty":-34.716764,"median":-34.716764,"eighty":-33.299512,"marketCap":25450475},{"date":"2025-05-16","current":-14.148502,"twenty":-34.716764,"median":-34.008138,"eighty":-15.063993,"marketCap":19666276},{"date":"2025-05-23","current":-14.074662,"twenty":-34.716764,"median":-18.309826,"eighty":-14.306662,"marketCap":21054484},{"date":"2025-05-30","current":-13.387434,"twenty":-34.716764,"median":-15.063993,"eighty":-14.061031,"marketCap":20026450},{"date":"2025-06-06","current":-14.702962,"twenty":-34.716764,"median":-14.800251,"eighty":-13.996937,"marketCap":21994367},{"date":"2025-06-13","current":-14.314495,"twenty":-34.716764,"median":-14.564634,"eighty":-14.061031,"marketCap":21413253},{"date":"2025-06-20","current":-13.774354,"twenty":-33.866413,"median":-14.548195,"eighty":-14.0474,"marketCap":20605249},{"date":"2025-06-27","current":-13.296895,"twenty":-33.299512,"median":-14.356338,"eighty":-13.867215,"marketCap":19891011},{"date":"2025-07-03","current":-13.774354,"twenty":-27.303638,"median":-14.27266,"eighty":-13.727614,"marketCap":20605249},{"date":"2025-07-11","current":-14.006506,"twenty":-17.177946,"median":-14.161274,"eighty":-13.727614,"marketCap":20952529},{"date":"2025-07-18","current":-13.851738,"twenty":-15.354982,"median":-14.154888,"eighty":-13.727614,"marketCap":20721009},{"date":"2025-07-25","current":-16.173259,"twenty":-16.219689,"median":-14.161274,"eighty":-13.727614,"marketCap":24193804},{"date":"2025-08-01","current":-13.464818,"twenty":-16.219689,"median":-14.199966,"eighty":-13.727614,"marketCap":20142210},{"date":"2025-08-08","current":-12.14929,"twenty":-16.049445,"median":-14.148502,"eighty":-13.573156,"marketCap":18174293},{"date":"2025-08-15","current":-12.265366,"twenty":-15.710284,"median":-14.056061,"eighty":-13.418388,"marketCap":18347933},{"date":"2025-08-22","current":-7.697345,"twenty":-15.447843,"median":-14.006506,"eighty":-13.015991,"marketCap":28547481},{"date":"2025-08-29","current":-6.307075,"twenty":-15.306558,"median":-13.929122,"eighty":-12.721932,"marketCap":23391328},{"date":"2025-09-05","current":-6.307075,"twenty":-15.146611,"median":-13.929122,"eighty":-12.474303,"marketCap":23391328},{"date":"2025-09-12","current":-6.578348,"twenty":-15.038217,"median":-13.851738,"eighty":-12.234412,"marketCap":24397407},{"date":"2025-09-19","current":-6.205348,"twenty":-14.9276,"median":-13.774354,"eighty":-7.507455,"marketCap":23014048},{"date":"2025-09-26","current":-6.049367,"twenty":-14.889578,"median":-13.773581,"eighty":-6.849619,"marketCap":22435553},{"date":"2025-10-03","current":-5.832349,"twenty":-14.826776,"median":-13.69697,"eighty":-6.578348,"marketCap":21630690},{"date":"2025-10-10","current":-6.307075,"twenty":-14.675296,"median":-13.542202,"eighty":-6.472551,"marketCap":23391328},{"date":"2025-10-17","current":-6.239257,"twenty":-14.561346,"median":-13.50351,"eighty":-6.415584,"marketCap":23139808},{"date":"2025-10-24","current":-5.879822,"twenty":-14.548195,"median":-13.387434,"eighty":-6.358617,"marketCap":21806754},{"date":"2025-10-31","current":-6.917438,"twenty":-14.538909,"median":-13.039206,"eighty":-6.374893,"marketCap":25655005},{"date":"2025-11-07","current":-8.524725,"twenty":-14.481047,"median":-12.845746,"eighty":-6.381675,"marketCap":31616021},{"date":"2025-11-14","current":-9.460613,"twenty":-14.381444,"median":-12.652286,"eighty":-6.415584,"marketCap":35086992},{"date":"2025-11-21","current":-5.852155,"twenty":-14.312928,"median":-12.458826,"eighty":-6.415584,"marketCap":30182359},{"date":"2025-11-28","current":-7.071353,"twenty":-14.306662,"median":-12.304058,"eighty":-6.374893,"marketCap":36470350},{"date":"2025-12-01","current":-7.071353,"twenty":-14.293061,"median":-12.284712,"eighty":-6.374893,"marketCap":36470350}],"updateTime":1787505456819},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"APUS\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1142452397","title":"SEC文件揭示：Freet已将全部Apitox相关权利转让予Apimeds Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=1142452397","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142452397?lang=zh_cn&edition=fundamental","pubTime":"2026-08-22 05:14","pubTimestamp":1787346850,"startTime":"0","endTime":"0","summary":"一项最新提交至美国证券交易委员会的文件显示，Apimeds Pharmaceuticals US已获得Freet方面转让的全部Apitox相关权益。这一动作意味着，围绕Apitox的所有权归属问题，如今已有了明确的界定与交接。根据该文件内容，Freet将其与Apitox相关的所有权利完整地转移给了Apimeds Pharmaceuticals。此举或将对Apimeds Pharmaceuticals未来的业务布局与产品管线产生深远影响。随着权利的正式移交，Apimeds Pharmaceuticals US如今握有更为集中的资源，未来其如何利用这一优势，值得持续关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111642266","title":"Apimeds Pharmaceuticals US获Apitox韩国诊所独家权利、美国25%特许权使用费及海外25%收入分成——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1111642266","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111642266?lang=zh_cn&edition=fundamental","pubTime":"2026-08-22 05:14","pubTimestamp":1787346850,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会最新披露的文件，Apimeds Pharmaceuticals US已就其核心产品Apitox达成一项重要协议。该公司获得了该产品在韩国诊所领域的100%独家权利，同时在美国市场享有25%的特许权使用费，并可参与海外市场25%的收入分成。协议条款清晰界定了各区域市场的利益分配机制——韩国市场侧重权利掌控，美国及海外市场则通过收益共享模式实现多方共赢。文件内容显示，此次权利与收益分配方案已正式确立，为Apitox的全球市场推广奠定了明确的商业框架。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170470171","title":"Apimeds制药美国公司依据和解协议，将在七个工作日内设立全新全资子公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1170470171","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170470171?lang=zh_cn&edition=fundamental","pubTime":"2026-05-06 02:09","pubTimestamp":1778004553,"startTime":"0","endTime":"0","summary":"根据最新达成的和解协议条款，Apimeds制药美国公司已承诺在七个工作日的期限内完成全新全资子公司的组建工作。这一举措标志着公司在战略重组方面迈出关键一步，旨在优化业务架构并提升运营效率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111825147","title":"Apimeds Pharmaceuticals US与Inscobee达成和解；合并进程继续，1亿美元PIPE融资即将完成，LŌKahi Therapeutics将推进Apitox项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1111825147","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111825147?lang=zh_cn&edition=fundamental","pubTime":"2026-05-06 02:07","pubTimestamp":1778004434,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceutical U.S, Inc.已与Inscobee达成和解协议，公司合并计划将按原定方案继续推进。与此同时，一项高达1亿美元的PIPE融资也即将完成交割。\n作为合并后实体的一部分，LŌKahi Therapeutics将获得资金支持，重点推进其Apitox项目的研发进程。这一系列进展标志着公司在战略布局和资本运作方面取得重要突破。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APUS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/APUS\",params:#limit:6,delay:false,,,undefined,":[]}}